GlassScriptPhysician profile
Edward W Jung
NPI 1003011941
$4,628.80
in general payments reported to CMS, 2019-2025
34 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,694 · 2020: $174 · 2021: $66.16 · 2022: $23.60 · 2023: $273 · 2024: $2,286 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Food and Beverage | $570.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,287.36 | 2019-2024 | Imfinzi, Tagrisso |
| Genentech USA, INC. | $331.47 | 2019 | |
| Novocure INC. | $227.77 | 2019-2024 | Optune |
| Elekta, INC. | $202.61 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $164.98 | 2019-2020 | |
| Amgen INC. | $153.74 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $117.47 | 2024 | Bravos Afterloader System |
| Aimmune Therapeutics, INC. | $111.65 | 2025 | Zenpep |
| Intuitive Surgical, INC. | $98.22 | 2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $85.50 | 2019-2021 | |
| Abbvie INC. | $82.31 | 2019-2020 | |
| Tesaro, INC. | $81.78 | 2019 | |
| Janssen Biotech, INC. | $74.88 | 2019 | |
| Sumitomo Pharma America, INC. | $73.04 | 2023 | Orgovyx |
| Incyte Corporation | $51.83 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $47.93 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $36.94 | 2019 | |
| Myriad Genetic Laboratories, INC. | $35.74 | 2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $33.15 | 2019-2020 | |
| Pfizer INC. | $31.63 | 2019 | |
| Merck Sharp & Dohme LLC | $29.34 | 2024 | Keytruda |
| Dendreon Pharmaceuticals LLC | $28.82 | 2019 | |
| Eisai INC. | $28.00 | 2019 | |
| Progenics Pharmaceuticals, INC. | $27.78 | 2023 | Pylarify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.76 | 2019-2020 | |
| Myovant Sciences INC. | $23.60 | 2022 | |
| Glaxosmithkline, LLC. | $19.79 | 2019 | |
| Astellas Pharma US INC | $19.74 | 2019 | |
| Daiichi Sankyo INC. | $19.17 | 2019 | |
| Tactile Systems Technology INC | $17.17 | 2020 | |
| Blue Earth Diagnostics | $16.52 | 2023 | |
| Exelixis INC. | $15.94 | 2019 | |
| Eusa Pharma (US) LLC | $12.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.